TrialEuropean journal of clinical pharmacology1990

Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II.

H Saxenhofer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.